関連する実験動画
Updated: Mar 24, 2026

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
36.7K
PKAの活性化により,メゼンキマから上皮への移行と腫瘍発起能力の喪失が起こる
Diwakar R Pattabiraman1, Brian Bierie1, Katharina Isabelle Kober1
1Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
まとめ
タンパク質キナーゼA (PKA) の活性化によるメゼンキマから上皮への移行 (MET) を誘導することで,がん幹細胞を排除することができる. このアプローチは腫瘍を誘発する細胞を再プログラムし 分化を促進し 癌の再発と転移を 誘発する能力を低下させます
科学分野:
- 腫瘍学
- 細胞生物学
- 分子生物学
背景:
- 癌細胞は上皮細胞からメゼンキマ細胞への移行 (EMT) を経て,悪性腫瘍に関連した特徴と腫瘍発起細胞 (TIC) の特性を獲得する.
- TICは癌の再発と転移の重要な要因で 重要な治療目標となります
研究 の 目的:
- メゼンキマのTICをエピテリア細胞に変換する方法を提案し,検証する.
- この治療移行を媒介する細胞内信号伝達経路の役割を調査する.
主な方法:
- 細胞内アデノシン3',5'- モノフォスファートとタンパク質キナーゼA (PKA) の活性化がヒト乳腺内膜細胞に与える影響を研究した.
- PKA活性化とヒストンデメチラーゼPHF2によるTICの表皮遺伝的再プログラミングを分析した.
主要な成果:
- 周期的なAMP濃度の上昇と,その後のPKA活性化により,メゼンキマ細胞のメゼンキマから上皮細胞への移行 (MET) が誘発された.
- PKAの活性化により,PHF2経由で表遺伝的再プログラムが引き起こされ,TICの分化と腫瘍開始能力の喪失が引き起こされた.
結論:
- この研究は,TICの差別化療法としてMETを誘導する可能性を示しています.
- タンパク質キナーゼA (PKA) は,がん細胞における上皮状態の強化と維持に重要な役割を果たします.
関連する概念動画
Interactions Between Signaling Pathways
7.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
Loss of Tumor Suppressor Gene Functions
6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
MAPK Signaling Cascades
9.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K

